Hospital Pharmacy & Compounding
FASTER RELEASE TO MARKET
Speed and quality are paramount in the Compounding Pharmacy Market. Knowing your product is free of contamination allows for faster release to market, giving you greater flexibility to respond to changes in demand and gives you a competitive advantage in the market.
Discover More Resources
NON-GROWTH BASED ALTERNATIVE STERILITY TESTING
This technical brief addresses the appropriate response to an out-of-specification sterility test when using a non-growth based rapid microbial method such as the SCANRDI® System that utilizes solid phase cytometry.
VALIDATION AND SUCCESSFUL IMPLEMENTATION OF SCANRDI®
While rapid microbiological methods (RMM) have been in common use by the food, health, and beauty aid industries for decades, the more highly regulated pharmaceutical industry has been slower to adopt them. The FDA supports RMMs for drug testing, as long as these alternative methods are validated to demonstrate their equivalency to the compendial methods.
CANDIDA ALBICANS: HOW IT AFFECTS THE PHARMACEUTICAL INDUSTRY
Candida albicans is an opportunistic pathogenic yeast and a common member of human gut flora. It is usually a commensal organism, but it can become pathogenic in immunocompromised individuals under certain conditions.